Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06580886 · ClinicalTrials.gov registry record
Validation of Handheld Ultrasound Devices in Rheumatology
A clinical trial, sponsored by Ottawa Hospital Research Institute.
- Completed
- Registry status
- 30
- Enrollment target
NCT06580886: Completed study, sponsored by Ottawa Hospital Research Institute.
NCT06580886 is a clinical trial that has completed, run by Ottawa Hospital Research Institute. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06580886 has completed, sponsored by Ottawa Hospital Research Institute.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test the concurrent validity of the Clarius handheld ultrasound devices versus gold-standard device to detect characteristic features of healthy and rheumatic joints in adults Psoriatic Arthtritis patients (i.e. anatomical structures and vascular flow).
Primary Outcome
After the imaging of all patients is completed, intraarticular synovitis scoring will be done based on the OMERACT definitions (scales of 0-3) as follows. Greyscale inflammatory (hypoechoic) synovial hyperplasia: Grade 0: no hypoechoic synovial hyperplasia Grade 1: minimal hypoechoic synovial hyperplasia (filling the angle between the periarticular bones, without bulging over the line linking tops of the bones) Grade 2: hypoechoic synovial hyperplasia bulging over the line linking tops of the
Interventions
- DEVICE Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-01-16 |
| Est. Completion | 2024-06-28 |
What the finished NCT06580886 record still lists
NCT06580886 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound is the first listed.
NCT06580886 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06580886 about?
NCT06580886 is a clinical study titled "Validation of Handheld Ultrasound Devices in Rheumatology". The goal of this clinical trial is to test the concurrent validity of the Clarius handheld ultrasound devices versus gold-standard device to detect characteristic features of healthy and rheumatic joints in adults Psoriatic Arthtritis patients (i.e. anatomical structures and vascular flow).
What is the current status of trial NCT06580886?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2023-01-16. Estimated completion is 2024-06-28.
What interventions are being tested in trial NCT06580886?
The interventions under investigation include: Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT06580886?
This trial is sponsored by Ottawa Hospital Research Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI